Michel Jadoul is an expert in Nephrology at Cliniques Universitaires Saint-Luc (Belgium). As of October 2026, ScienceLeadR ranks Michel Jadoul in the top 1% of experts worldwide for Renal Insufficiency. Michel Jadoul has authored 472 publications, the most recent in 2028, and is an investigator in 14 clinical trials. SLR score: 1,564 (community average: 125). How the SLR is computed.

LeadR Profile

1 564 ScienceLeadR Reputation 1564
Network Map

Nephrology

Subspecialties: Transplantation - Cardiology - Urology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1988 - 2028

Source: PubMed

Cliniques Universitaires Saint-Luc

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 472

Citations

Citations: 27 470 1st author: 59 Last author: 89 Unique author: 15


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Effects of Sodium Zirconium Cyclosilicate on Volume Status in Maintenance Hemodialysis: Post Hoc Analysis from the DIALIZE-Outcomes Trial.
PMID 42560771 — hyperkalemia, blood, arrhythmias, cardiac, blood pressure, kidney, maintenance, antihypertensive agents, therapeutics
Kidney36020260
KDIGO Workshop Report on the Implementation and Expansion of Home Hemodialysis in East Asia: A Focus on Hong Kong, Japan, Korea, and Taiwan.
PMID 42518526 — hemodialysis, home, kidney, therapeutics
Kidney Int Rep20260
Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases: A Randomized Clinical Trial.
PMID 42246414 — kidney diseases, creatinine, albuminuria, kidney
JAMA Top journal20260
The Kidney in the Middle: KDIGO Guidelines Address Multiple Key Components of Cardiovascular-Kidney-Metabolic Syndrome.
PMID 42191113 — diabetes mellitus, kidney diseases, kidney, obesity, metabolic syndrome
Kidney Int20260
Kidney Disease: Improving Global Outcomes Green Dialysis Controversies Conference: A Carbon Footprint and Sustainability Report.
PMID 42180824 — kidney diseases, carbon footprint, kidney, environment
Kidney Int Rep20260

Clinical Studies 14

Sources: ClinicalTrials, EU CTIS

Synthesis

Study Chair: 1

By phase:

Phase 3 10
N/A 2
Phase 2 2

By status:

Completed 7
Terminated 5
Unknown 2

By type:

Interventional 13
Observational 1

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 1
multicentric5to9 0
multicentricup10 9

Main Topics

Cohort/Consortium Investigators 2

LeadR Networks

Main global connection map